v3.26.1
Condensed Statements of Cash Flows - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:        
Net loss $ (2,510,314) $ (1,665,246) $ (9,491,534) $ (793,749)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization 5,634 496 13,999 270
Stock-based compensation expense 981,455 1,440,777 7,232,145 619,867
Non-cash legal expense financed by note payable    
Non-cash interest expense     994
Changes in operating assets and liabilities:        
Prepaid expenses and other current assets 399,429 (112) (400,589)
Accounts payable and accrued expenses 706,176 23,676 438,991 24,235
Net cash used in operating activities (417,620) (247,761) (2,198,494) (149,377)
Cash flows from investing activities:        
Purchase of property and equipment (11,139) (10,050)
Acquisition of intangible asset (25,000)   (25,000)
Net cash used in investing activities (11,139) (25,000) (10,050)
Cash flows from financing activities:        
Proceeds from issuance of common stock, net of offering costs     2,472,606
Proceeds from related parties     6,063
Proceeds from shares issued 650,000
Net cash provided by financing activities 650,000 2,478,669
Net change in cash and cash equivalents 221,241 (247,761) (2,223,494) 2,319,242
Cash and cash equivalents at beginning of year 95,748 2,319,242 2,319,242
Cash and cash equivalents at end of year 316,989 2,071,481 95,748 2,319,242
Supplemental disclosure of cash flow information:        
Cash paid for income taxes    
Cash paid for interest    
Supplemental disclosure of non-cash financing activities:        
Warrants issued in acquisition of intangibles     283,287
Shares issued pursuant to settlement of payables     593,670
Note payable issued for legal expense     $ 7,500
Conversion of note payable and accrued interest into common stock $ 8,579